Skip to main content
. 2015 Feb 27;3(3):639–648. doi: 10.3892/mco.2015.520

Table III.

Stratified analysis of the association between folate-related gene polymorphisms and colorectal cancer risk.

Variables Models MTHFR 677C>T AOR (95% CI)a P-value MTHFR 1298A>C AOR (95% CI)a P-value TSER 2R/3R AOR (95% CI)a P-value TS 1494 0bp/6bp AOR (95% CI)a P-value RFC1 −43T>C AOR (95% CI)a P-value RFC1 80G>A AOR (95% CI)a P-value RFC1 696C>T AOR (95% CI)a P-value
Age, years
  ≤62 D 0.88 (0.59–1.32) 0.545 1.05 (0.69–1.61) 0.809 0.76 (0.51–1.14) 0.187 0.69 (0.47–1.00) 0.052 0.75 (0.47–1.21) 0.239 0.73 (0.45–1.17) 0.191 0.74 (0.46–1.18) 0.204
R 1.15 (0.67–1.97) 0.623 1.67 (0.39–7.21) 0.495 1.43 (0.31–6.58) 0.647 0.72 (0.37–1.43) 0.349 1.27 (0.85–1.92) 0.249 1.19 (0.80–1.77) 0.397 1.07 (0.71–1.62) 0.734
  >62 D 1.32 (0.89–1.96) 0.170 1.05 (0.70–1.58) 0.802 1.63 (1.09–2.43) 0.017 1.04 (0.72–1.50) 0.837 1.41 (0.89–2.21) 0.141 1.55 (0.97–2.47) 0.066 1.50 (0.96–2.35) 0.076
R 0.83 (0.50–1.38) 0.482 3.65 (1.04–12.73) 0.043 1.34 (0.46–3.96) 0.591 1.71 (0.90–3.25) 0.101 1.30 (0.86–1.96) 0.207 0.97 (0.65–1.44) 0.876 1.14 (0.76–1.73) 0.527
Gender
  Male D 1.02 (0.70–1.48) 0.929 1.21 (0.81–1.80) 0.347 1.03 (0.70–1.49) 0.895 0.84 (0.59–1.19) 0.321 1.01 (0.67–1.52) 0.976 0.99 (0.65–1.50) 0.946 0.97 (0.65–1.46) 0.888
R 0.78 (0.47–1.29) 0.334 1.39 (0.37–5.20) 0.624 0.98 (0.32–3.04) 0.972 1.26 (0.69–2.32) 0.449 1.35 (0.92–1.98) 0.129 1.14 (0.78–1.65) 0.499 1.16 (0.78–1.71) 0.460
  Female D 1.03 (0.68–1.55) 0.900 0.89 (0.58-.36) 0.588 1.21 (0.80–1.85) 0.369 0.83 (0.56–1.23) 0.358 1.05 (0.63–1.75) 0.861 1.12 (0.66–1.90) 0.677 1.16 (0.70–1.93) 0.560
R 1.18 (0.69–2.02) 0.545 4.62 (1.20–17.80) 0.026 2.18 (0.59–8.08) 0.242 1.02 (0.51–2.07) 0.949 1.26 (0.82–1.94) 0.287 1.03 (0.68–1.56) 0.886 1.07 (0.69–1.64) 0.772
HTN
  No D 0.90 (0.60–1.36) 0.623 0.76 (0.49–1.17) 0.208 1.19 (0.78–1.81) 0.424 1.01 (0.68–1.50) 0.972 0.88 (0.55–1.41) 0.603 0.79 (0.49–1.27) 0.329 0.90 (0.56–1.43) 0.653
R 0.67 (0.37–1.23) 0.201 1.67 (0.48–5.80) 0.416 7.36 (1.44–37.58) 0.016 1.65 (0.84–3.28) 0.149 1.49 (0.96–2.30) 0.076 1.28 (0.84–1.95) 0.260 1.26 (0.80–1.97) 0.320
  Yes D 1.09 (0.75–1.59) 0.660 1.30 (0.88–1.94) 0.190 1.04 (0.72–1.52) 0.821 0.76 (0.53–1.07) 0.116 1.05 (0.68–1.63) 0.815 1.24 (0.79–1.93) 0.347 1.15 (0.75–1.77) 0.524
R 1.07 (0.66–1.72) 0.787 3.63 (0.76–17.36) 0.106 0.65 (0.22–1.96) 0.444 0.88 (0.48–1.63) 0.691 1.10 (0.76–1.60) 0.616 0.88 (0.61–1.27) 0.504 0.97 (0.67–1.41) 0.878
DM
  No D 0.93 (0.68–1.27) 0.627 1.03 (0.74–1.42) 0.867 1.21 (0.88–1.66) 0.248 0.81 (0.60–1.09) 0.156 0.94 (0.65–1.35) 0.730 0.94 (0.65–1.36) 0.738 0.96 (0.66–1.37) 0.804
R 0.92 (0.60–1.40) 0.687 2.00 (0.68–5.92) 0.211 1.65 (0.67–4.11) 0.279 1.02 (0.62–1.69) 0.943 1.46 (1.06–2.02) 0.020 1.14 (0.84–1.56) 0.406 1.24 (0.90–1.72) 0.188
  Yes D 1.19 (0.68–2.11) 0.540 1.01 (0.56–1.82) 0.976 0.90 (0.51–1.57) 0.699 1.05 (0.61–1.82) 0.863 1.23 (0.65–2.34) 0.530 1.24 (0.64–2.39) 0.525 1.27 (0.68–2.38) 0.452
R 0.93 (0.4–1.93) 0.841 3.76 (0.46–30.92) 0.218 0.84 (0.07–9.67) 0.891 2.34 (0.65–8.43) 0.194 0.84 (0.47–1.50) 0.548 0.84 (0.47–1.49) 0.555 0.75 (0.41–1.35) 0.330
Tumor site
  Colon D 0.98 (0.71–1.36) 0.915 0.90 (0.64–1.26) 0.526 1.05 (0.76–1.46) 0.757 0.78 (0.58–1.06) 0.117 1.21 (0.82–1.78) 0.331 1.17 (0.79–1.73) 0.432 1.19 (0.82–1.75) 0.361
R 0.90 (0.58–1.39) 0.631 2.01 (0.69–5.82) 0.198 0.95 (0.31–2.92) 0.932 1.21 (0.72–2.04) 0.479 1.36 (0.98–1.89) 0.065 1.08 (0.79–1.50) 0.620 1.17 (0.84–1.63) 0.359
  Rectum D 1.02 (0.71–1.46) 0.922 1.25 (0.86–1.80) 0.238 1.15 (0.80–1.65) 0.440 0.97 (0.69–1.36) 0.876 0.80 (0.54–1.20) 0.297 0.86 (0.57–1.30) 0.476 0.87 (0.58–1.29) 0.489
R 1.01 (0.63–1.60) 0.982 3.27 (1.13–9.47) 0.029 1.97 (0.72–5.38) 0.186 1.14 (0.63–2.05) 0.665 1.11 (0.77–1.61) 0.578 0.97 (0.68–1.39) 0.879 0.93 (0.64–1.36) 0.702
Tumor size
  < 5cm D 1.20 (0.83–1.73) 0.338 0.76 (0.51–1.12) 0.163 1.01 (0.70–1.45) 0.978 0.83 (0.59–1.17) 0.296 0.99 (0.65–1.49) 0.947 0.95 (0.63–1.44) 0.804 1.04 (0.69–1.56) 0.864
R 1.25 (0.80–1.95) 0.337 1.17 (0.32–4.29) 0.816 1.59 (0.55–4.59) 0.393 0.66 (0.33–1.33) 0.247 1.00 (0.69–1.46) 0.989 0.89 (0.62–1.29) 0.544 0.90 (0.62–1.33) 0.609
  ≥ 5cm D 0.86 (0.63–1.19) 0.370 1.28 (0.92–1.77) 0.141 1.17 (0.85–1.61) 0.348 0.86 (0.63–1.16) 0.311 1.00 (0.69–1.46) 0.984 1.08 (0.73–1.58) 0.709 0.99 (0.69–1.42) 0.948
R 0.74 (0.47–1.16) 0.189 3.63 (1.38–9.53) 0.009 1.40 (0.52–3.81) 0.509 1.57 (0.96–2.56) 0.072 1.44 (1.05–1.99) 0.026 1.14 (0.83–1.57) 0.412 1.18 (0.85–1.64) 0.315
L/N invasion
  No D 0.82 (0.59–1.14) 0.248 1.08 (0.77–1.52) 0.665 1.14 (0.81–1.58) 0.457 0.88 (0.65–1.21) 0.436 0.77 (0.53–1.11) 0.162 0.88 (0.60–1.28) 0.496 0.77 (0.53–1.11) 0.161
R 1.00 (0.65–1.54) 0.994 2.32 (0.80–6.77) 0.123 2.81 (1.17–6.76) 0.021 1.00 (0.57–1.77) 0.994 1.04 (0.73–1.47) 0.838 0.81 (0.58–1.14) 0.237 0.88 (0.61–1.25) 0.466
  Yes D 1.23 (0.87–1.75) 0.249 1.00 (0.70–1.43) 1.000 1.05 (0.75–1.49) 0.766 0.80 (0.58–1.10) 0.173 1.39 (0.91–2.11) 0.129 1.22 (0.80–1.84) 0.354 1.42 (0.94–2.16) 0.100
R 0.89 (0.56–1.40) 0.606 2.71 (0.94–7.76) 0.064 0.21 (0.03–1.65) 0.137 1.35 (0.79–2.32) 0.271 1.52 (1.08–2.14) 0.017 1.33 (0.95–1.85) 0.097 1.30 (0.92–1.84) 0.141
a

Models adjusted for age, gender, hypertension and diabetes mellitus status. MTHFR, methylenetetrahydrofolate reductase; TS, thymidylate synthase; TSER, TS enhancer region; RFC1, reduced folate carrier 1; AOR, adjusted odds ratio; CI, confidence interval; D, dominant; R, recessive; HTN; hypertension; DM, diabetes mellitus; L/N, lymph node.